Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupuncture in Addition to Usual Care for the Treatment of Refractory Irritable Bowel Syndrome: a Randomized Controlled Trial

NCT04276961 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT04276961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupuncture in Addition to Usual Care for the Treatment of Refractory Irritable Bowel Syndrome: a Randomized Controlled Trial
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
October 15, 2020
Completion date
June 1, 2022
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome